LifeMD, Inc. LFMD
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.11% | 2.49% | 6.41% | 5.67% | 10.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.11% | 2.49% | 6.41% | 5.67% | 10.46% |
| Cost of Revenue | -13.17% | -1.39% | 23.35% | 53.92% | 43.61% |
| Gross Profit | 5.83% | 3.08% | 4.14% | 0.14% | 6.36% |
| SG&A Expenses | 8.63% | 1.70% | -4.06% | -4.53% | 1.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 23.44% | 33.85% | 23.02% | 39.71% | 36.36% |
| Total Operating Expenses | 6.13% | 2.35% | -0.10% | 2.26% | 7.10% |
| Operating Income | -54.62% | -0.38% | 65.79% | 37.71% | 27.99% |
| Income Before Tax | -39.24% | 0.68% | 57.52% | 28.19% | 24.89% |
| Income Tax Expenses | -77.97% | -77.97% | -77.97% | 16.14% | 94.04% |
| Earnings from Continuing Operations | -32.96% | 4.39% | 58.28% | 26.69% | 22.34% |
| Earnings from Discontinued Operations | 295.81% | 570.24% | 1,646.36% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 81.23% | 23.65% | -130.63% | -113.98% | 28.94% |
| Net Income | 101.76% | 138.22% | 167.05% | 47.79% | 47.38% |
| EBIT | -54.62% | -0.38% | 65.79% | 37.71% | 27.99% |
| EBITDA | -230.37% | -82.65% | 54.88% | 79.17% | 66.46% |
| EPS Basic | 83.17% | 112.41% | 139.24% | 46.86% | 48.02% |
| Normalized Basic EPS | -67.66% | -22.73% | 44.73% | 59.98% | 58.10% |
| EPS Diluted | 83.05% | 111.92% | 138.59% | 46.41% | 47.55% |
| Normalized Diluted EPS | -67.66% | -22.73% | 44.73% | 59.98% | 58.10% |
| Average Basic Shares Outstanding | 9.49% | 9.49% | 9.53% | 10.41% | 13.18% |
| Average Diluted Shares Outstanding | 9.49% | 9.49% | 9.53% | 10.41% | 13.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 57.69% | 3.62% | 2.49% | -0.92% | -0.90% |